Early discontinuation of tamoxifen: A lesson for oncologists [3]

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2595-2596
Number of pages2
JournalCancer
Volume110
Issue number11
DOIs
StatePublished - Dec 1 2007

Fingerprint

Hormonal Antineoplastic Agents
Treatment Refusal
Polypharmacy
Fluoxetine
Tamoxifen
Antidepressive Agents
Oncologists

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Early discontinuation of tamoxifen : A lesson for oncologists [3]. / Goetz, Matthew Philip; Ingle, James.

In: Cancer, Vol. 110, No. 11, 01.12.2007, p. 2595-2596.

Research output: Contribution to journalArticle

Goetz, Matthew Philip ; Ingle, James. / Early discontinuation of tamoxifen : A lesson for oncologists [3]. In: Cancer. 2007 ; Vol. 110, No. 11. pp. 2595-2596.
@article{2468847914c5427eb89e2655704712f7,
title = "Early discontinuation of tamoxifen: A lesson for oncologists [3]",
author = "Goetz, {Matthew Philip} and James Ingle",
year = "2007",
month = "12",
day = "1",
doi = "10.1002/cncr.23064",
language = "English (US)",
volume = "110",
pages = "2595--2596",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Early discontinuation of tamoxifen

T2 - A lesson for oncologists [3]

AU - Goetz, Matthew Philip

AU - Ingle, James

PY - 2007/12/1

Y1 - 2007/12/1

UR - http://www.scopus.com/inward/record.url?scp=36448966374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448966374&partnerID=8YFLogxK

U2 - 10.1002/cncr.23064

DO - 10.1002/cncr.23064

M3 - Article

C2 - 17896782

AN - SCOPUS:36448966374

VL - 110

SP - 2595

EP - 2596

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -